Introduction
============

Basigin, which is also known as CD147 or EMMPRIN (extracellular matrix metalloproteinase inducer), encodes a transmembrane glycoprotein with two immunoglobulin-like domains [@B1], [@B2]. Basigin is expressed in various tissues and is involved in a number of physiological processes, including spermatogenesis [@B3], [@B4], fertilization [@B5], embryo implantation [@B3], [@B5], and neural functions, such as vision, behavior, memory, and olfaction [@B6]-[@B8]. Within the thymus, the expression level of basigin correlates with various differentiation stages of thymocytes, with the highest expression level found in early immature thymocytes. Treatment of immature fetal thymocytes using an anti-basigin monoclonal antibody (mAb) blocked thymocyte maturation *ex vivo*[@B9]. In adults, basigin was identified as a lymphocyte activation-associated antigen [@B10]. Moreover, its expression was also significantly upregulated in activated T lymphocytes. MAbs specific for basigin inhibited anti-CD3-induced T lymphocyte activation, presumably via the inhibition of the reorganization and clustering of GPI-anchored co-receptors within lipid rafts, which, in turn, altered downstream signaling events [@B11]. Our previous study showed that basigin was functionally linked to the formation of the immunological synapse [@B12]. However, the precise function and mechanism of basigin in regulating thymus development and T cell functions *in vivo* remains to be clarified. Basigin is also expressed in a large number of pathological conditions, including inflammation [@B13], [@B14], tissue repair/remodeling [@B15], ischemic disease [@B16], [@B17] and Alzheimer\'s disease [@B18]. It has been well established that basigin is overexpressed on the surface of tumor cells, and plays significant roles in tumor growth, angiogenesis, invasion, and metastasis by inducing the secretion of various matrix metalloproteinases [@B19], stimulating the production of vascular endothelial growth factor [@B20], activating cell signaling pathways [@B21], [@B22], preventing anoikis [@B23], and regulating metabolism [@B24], among others. Furthermore, overexpression of basigin in tumor tissues is correlated with the poor prognosis of patients with several types of solid tumors [@B25]-[@B28]. These results indicated that basigin is a widely expressed multifunctional protein and is implicated in a variety of physiological and pathological conditions.

Although basigin has been recognized to be a multifunctional protein, the molecular mechanisms underlying its diverse functions have yet to be elucidated. To examine the functions of basigin *in vivo*, Igakura *et al.* generated a *basigin* (*Bsg*) null mutant mouse (*Bsg^-/-^*) using a conventional gene targeting strategy [@B3]. Using this mouse model, they revealed that basigin played a critical role in embryo implantation, reproduction, physiological neural functions, and the mitogenic response of lymphocytes upon a mixed lymphocytic response [@B4], [@B5], [@B29]. However, because most of the *Bsg^-/-^* embryos died around the time of implantation and only a small number of *Bsg^-/-^* embryos survived until birth and into adulthood, it was very difficult to obtain a sufficient number of *Bsg^-/-^* mice for a more detailed phenotypic analysis. Moreover, the *Bsg^-/-^* mice that did survive into adulthood were smaller and weaker compared to wildtype controls. In addition, both male and female*Bsg*^-/-^mice were infertile, which prevented the establishment of several disease models for the study of the functions of basigin in a pathological context. Furthermore, knocking out the expression of basigin ubiquitously in all tissues prevented the ability to study its roles in specific tissues or at specific developmental stages, as well as the corresponding cellular and molecular mechanisms.

To overcome these disadvantages, we generated a conditional null allele for *basigin*using the *Cre-loxP* system. We also ablated the *basigin* gene in thymocytes and T lymphocytes using *Lck-Cre* transgenic mice. We found that *Lck-Cre; Bsg^fl/fl^* mice exhibited a significant reduction in the number of DP (double positive, CD4^+^CD8^+^) and CD4SP (single positive, CD4^+^CD8^-^) thymocytes, and a high proliferation index of CD4^+^ T cells upon Concanavalin A (Con A) or anti-CD3/CD28 stimulation. To the best of our knowledge, this is the first study to provide insight into the *in vivo* role of *basigin* in thymocytic development. Moreover, *basigin* conditional null mice will be a valuable genetic tool used to uncover the *in vivo* role of *basigin* in specific tissues and at specific developmental stages.

Materials and Methods
=====================

Construction of the Targeting Vector
------------------------------------

The *basigin* conditional gene targeting vector was generated based on a PCR-based cloning strategy as previously described [@B30]. *Basigin* genomic DNA isolated from R1 ES cells (on 129/SV background) was used. To generate the targeting vector, the *basigin* fragment containing exons 2-7, a 1.5-kb fragment of the 5\' arm and a 3.7-kb fragment of the 3\' arm were amplified using PCR. The following PCR primers were synthesized by Invitrogen and used in this study: *Basigin* fragment with exons 2-7 primers: 5\'-GTCGACCTTGTAGTAACGGGTACTAACCCTT-3\' and 5\'-ATCGATGACACACACATTGAGTCCCAGAGCA-3\'; 5\' arm primers: 5\'-AAGGAAAAAAGCGGCCGCAGGCTGAATTTGATATTAGGGTCTC-3\' and 5\'-CCGCTCGAGCTCCATTTCTTTTCTGCTTGCGGGG-3\'. 3\' arm primers: 5\'-CCCATCGATAGATCTATAACTTCGTATAATGTATGCTATACGAAGTTATAGGTGGATGGCTGCTGTTGAAATAA-3\' and 5\'-CGGGGTACCCAGTTAATCAATGGTTGATCAATCG-3\'. The forward primer of the 3\' arm was designed to introduce a *Bgl II* site and a *loxP* site into the PCR product. High-fidelity Taq polymerase (TaKaRa) was used for PCR amplification and all of the PCR products were confirmed by sequencing. These fragments were sequentially subcloned into the *pfrtI* vector (developed in our lab). A schematic of the conditional *basigin* targeting vector is shown in Fig. [1](#F1){ref-type="fig"}A.

Generation of Mice Carrying a conditional null allele for *basigin*
-------------------------------------------------------------------

After linearization by *Not I* (TaKaRa), the targeting vector was transfected into R1 ES cells. Colonies resistant to G418 and ganciclovir were screened by Southern blot and PCR. Correctly targeted ES cells were then microinjected into C57BL/6 blastocysts to generate chimeric mice, which were further bred to C57BL/6 mice to generate F1 offspring. The conditional *basigin* allele (*Bsg^fn^*) mice were bred with *Flp* transgenic mice to delete the *FRT* flanked *Neo*cassette to produce *Bsg^fl^* mice, which were then bred with *Lck-Cre* transgenic mice to generate *Lck-Cre; Bsg^fl/fl^*mice. All of the mice used in this study were housed in a specific pathogen-free facility. Moreover, all of the animal work was approved by the Fourth Military Medical University\'s institutional animal care and use committee and handled in strict accordance with good animal practice as defined by the relevant national animal welfare bodies.

Genotypic analyses
------------------

Mouse genotypes were analyzed using Southern blot and PCR. Genomic DNA from ES cells and tissues were prepared according to standard protocols. A Southern blot was performed using a digoxigenin-based labeling and detection kit (Roche) according to the manufacturer\'s instructions. The 5\' arm homologous recombination was identified by PCR using a *Neo*-specific primer pair, P1: 5\'-ACAGACCCATAGCCTACAGC-3\' and P2: 5\'-GCTACTTCCATTTGTCACGT-3\', expected to amplify a fragment of 2.1 kb in *Bsg^fn^*alleles. The *loxP* site flanked exon 7 was identified using a primer pair, P3: 5\'-CTCTGGGACTCAATGTGTGT-3\' and P4: 5\'-AGGTGGGTTTTCTGTAAGGT-3\', which was expected to amplify a 371-bp fragment in the wildtype allele and a 405-bp fragment in the targeted allele. The Flp-mediated deletion of the *Neo*cassette was identified using the primer pair, P5: 5\'-CTGGAACTCCTAGCAATC-3\' and P6: 5\'-TGGGAAAGGGTTAGTAC-3\', which was expected to amplify a 445-bp fragment in the *Neo*-deleted allele (*Bsg^fl^*) and a 377-bp fragment in the wildtype allele. The Cre-mediated deletion of the floxed exons 2 to 7 was identified using the primer pair, P7: 5\'-CTGGAACTCCTAGCAATC-3\' and P4, which was expected to amplify a 614-bp fragment (referred to as the deleted band). All of the PCR reactions were performed for 30 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 0.5 or 2 minutes.

Cell isolation
--------------

Spleens and thymuses were harvested from five-week-old mice and mechanically disrupted through a 70-µm strainer. After treatment with red blood cell lysis buffer (0.14 M NH~4~Cl in HEPES, pH 7.0), the cells were washed with a sterile phosphate buffer solution (PBS) and resuspended as a single cell suspension. The absolute cell number was quantified. The splenocytes were further isolated using a mouse CD4^+^ T cell-specific and B cell-specific isolation kit according to the manufacturer\'s instructions (Miltenyi Biotec Inc.). The purity of the obtained cells was further detected using flow cytometry with CD4 or CD19 mAbs (BD-Biosciences). Only cells with a purity greater than 95% were used for further analysis.

Real-time quantitative PCR
--------------------------

Total RNA obtained from isolated CD4^+^ T and B cells was extracted using Trizol reagent (Invitrogen). Single strand cDNA was synthesized from 1 μg of total RNA using the RNA reverse transcriptase kit (Takara). Real-time quantitative PCR was performed using the ABI PRISM 7000 Sequence Detection System (Applied Biosystems), and the TAKARA SYBR Premix Ex Taq was used for amplification according to the manufacturer\'s instructions. The mRNA level of *basigin* was detected using the primer pair, Bsg-1: 5\'-TGGACCGTGTTCACATCCAT-3\' and Bsg-2: 5\'-ACCTCTTTAGCATAGTAGTCCGC-3\'. β-actin was detected using the primer pair: Actin-1: 5\'-GGCTGTATTCCCCTCCATCG-3\' and Actin-2: 5\'-CCAGTTGG TAACAA TGCCATGT-3\'.

Western blotting analyses
-------------------------

Freshly isolated CD4^+^T cells and B cells were immediately homogenized in protein lysis buffer. Thirty-micrograms of protein were isolated on 10% SDS-PAGE, transferred onto a PVDF membrane, and blotted using a goat-anti-basigin antibody (R&D Systems) or rabbit-anti-β-actin antibody (R&D Systems). After several washes, the membranes were incubated with HRP-conjugated anti-goat or anti-rabbit IgG (R&D Systems) and then visualized using ECL reagents (Amersham Bioscience).

Flow cytometry
--------------

Flow cytometry was performed according to previously described methods [@B9]. Freshly prepared single-cell suspensions of thymuses and spleens from at least eight animals per genotype were incubated using anti-CD16/32 to block FcRγ II/III, followed by staining with fluorochrome-conjugated mAbs. All of the antibodies were purchased from BD-Biosciences. Stained cells were analyzed using a FACSCalibur flow cytometer (BD-Biosciences) and CellQuest software (BD-Biosciences). The absolute cell number of each cell subset was calculated by the percentage of stained cells × total cell number.

T cell proliferation assay
--------------------------

Purified CD4^+^ T cells (5×10^4^ cells/well) were incubated with either medium alone or with ConA (1 μg/mL, Sigma-Aldrich), plate-bound anti-CD3 and anti-CD28 (5 μg/mL and 5 μg/mL, BD-Biosciences, respectively), and PMA/Ionomycin (25 ng/mL/500 ng/mL, Sigma-Aldrich) for 72 hours at 37°C in 96-well plates. Next, 20 μL of 20 μg/mL WST-1 (Roche) were added into each well, and the cultures were incubated at 37°C for an additional 4 hours. Next, the absorbance was measured at 450 nm and 630 nm. The proliferation index was calculated as (A450 nm - A630 nm) of the T cells cultured with different mitogens divided by (A450 nm - A630 nm) of the T cells cultured with medium alone.

Statistical analysis
--------------------

The Graphpad prism software was used to manage the data. The results are presented as the means ± SD, and two-tailed Student\'s *t*-test was used to compare the significance between two groups. \**P* \< 0.05 was considered significant.

Results
=======

Generation of a conditional null allele for *basigin* in mice
-------------------------------------------------------------

The murine *Bsg* gene spans over 7.6 kb on chromosome 10 and contains 8 exons, including the noncoding exon 1 [@B31]. The full-length transcript of *basigin* is approximately 3.1 kb and encodes two isoforms of the basigin proteins 1 and 2, depending on the alternative splicing of exon 2. Because the gene fragment from exon 2 to exon 7 encodes over 97% of *basigin* amino acids, and deletion of this fragment will introduce a frame shift mutation in exon 8, a deletion of the gene fragment from exon 2 to exon 7 using*Cre* recombinase is expected to result in a null allele of basigin for both isoforms. To generate a conditional null allele for *basigin*, we flanked exon 2 and exon 7 with two *loxP* sites. The *pfrtI*vector, which contains a*Neo*cassette flanked by two*FRT*sites, a *loxP*site and an *Hsv-tk* cassette, was used to construct the conditional gene targeting vector. First, we inserted a 1.5-kb fragment located in intron 1 of *basigin*into the *pfrtI* vector for the 5\' homology recombination arm, and then inserted a 3.2-kb fragment containing exons 2 to 7 downstream of the*loxP* site into the *pfrtI* vector, followed by a 3.7-kb fragment containing a second *loxP* site and exon 8 inserted into the *pfrtI* vector to form the 3\' homology recombination arm (Fig. [1](#F1){ref-type="fig"}A). After linearization by *Not I*, the targeting vector was electroporated into R1 embryonic stem cells (ES). Three out of 192 (1.6%) ES clones with G418- and ganciclovir- resistance showed correct recombination as detected by Southern blot using an external 3\' probe, which exhibited a 4.1-kb targeted allele (referred to as *Bsg^fn^*, fn denotes floxP-neo) band in addition to an 8.1-kb wildtype allele (referred to as *Bsg^+^*) band (Fig. [1](#F1){ref-type="fig"}A and [1](#F1){ref-type="fig"}B). The 5\' arm homologous recombination event of the targeted ES clones was also confirmed by PCR using a *Neo* specific primer pair, P1 and P2, which amplified a unique 2.1-kb fragment of the *Bsg^fn^* allele, but not the *Bsg^+^* allele (Fig. [1](#F1){ref-type="fig"}A and [1](#F1){ref-type="fig"}C). These results demonstrated that three targeted ES clones with the floxed *basigin* allele (*Bsg^fn^*) had been successfully generated.

The correctly targeted ES cells were then microinjected into blastocysts obtained from 129/SV mice to generate chimeric mice according to standard protocols [@B32]. F1 mice were analyzed by PCR using primers P3 and P4 to validate germline transmission of the *Bsg^fn^* allele (data not shown). Because the *Neo*cassette located in intron 1 could potentially disrupt basigin mRNA transcription, splicing, or stability, we removed it by crossing the *Bsg^fn/+^* mice to *Flp* transgenic mice [@B33], which resulted in *Bsg^fl/+^* mice (Fig. [1](#F1){ref-type="fig"}A, f denotes floxP). The deletion of the *Neo*cassette was confirmed by PCR with primers P5 and P6, which amplified a 445-bp fragment from the *Bsg^fl^* allele but only a 377-bp fragment from the wildtype allele (Fig. [1](#F1){ref-type="fig"}A and [1](#F1){ref-type="fig"}D). Heterozygous *Bsg^fl/+^* mice were intercrossed to generate homozygous *Bsg^fl/fl^*mice, which were born at the expected Mendelian ratio (*Bsg^+/+^*: *Bsg^fl/+^*: *Bsg^fl/fl^*= 54: 117: 61). Both male and female *Bsg^fl/fl^* mice were viable, fertile, and presented no genotype-dependent differences in gross morphological abnormalities, indicating that the floxed basigin allele (*Bsg^fl^*) was a functional basigin allele.

Conditional deletion of *basigin* allele using *Lck-Cre* transgenic mice
------------------------------------------------------------------------

To demonstrate that the *Bsg^fl^*allele could be deleted using Cre recombinase *in vivo*and to obtain additional information regarding the role of *basigin* in thymocyte development and T lymphocyte activation, *Bsg^fl/fl^* mice were mated to *Lck-Cre* transgenic mice, which have been successfully used to delete floxed genes in thymocytes and T lymphocytes [@B34]. We designed PCR primers (Fig. [1](#F1){ref-type="fig"}A) to amplify the deleted allele (using primers P7 and P4; 614-bp product in length) and undeleted allele (using primers P3 and P4; 405-bp product in length). The PCR results showed no deleted band in tissues obtained from control mice, but a strong deleted band in genomic DNA from the thymus, a moderate band in the spleen, and no deleted allele band in the genomic DNA from liver of the *Lck-Cre; Bsg^fl/fl^ mice* (Fig. [2](#F2){ref-type="fig"}A) was observed, which was consistent with the level of T lymphocytes in these tissues. However, a very weak undeleted band in the PCR results of the thymus was still present, which might have been amplified from the genomic DNA of cells lacking *Cre* expression in the thymus, such as thymic epithelial cells. To further investigate whether *Lck-Cre*-mediated excision of the *Bsg^fl^* allele was T lymphocyte-specific, we isolated CD4^+^ T lymphocytes and CD19^+^ B lymphocytes from the spleen and measured the basigin expression both at the mRNA and protein level. Real-time quantitative PCR data showed that *basigin*mRNA was normal in CD4^+^ T lymphocytes from control *Bsg^fl/fl^*mice, but was undetectable in the CD4^+^ T lymphocytes from *Lck-Cre; Bsg^fl/fl^*mice. However, the basigin mRNA level in B lymphocytes showed no difference between mice of the two different genotypes (Fig. [2](#F2){ref-type="fig"}B). Using a western blotting analysis, the specific deletion of basigin protein in CD4^+^ T lymphocytes of *Lck-Cre; Bsg^fl/fl^* mice was also verified using an anti-basigin antibody (Fig. [2](#F2){ref-type="fig"}C). These results demonstrated that the *Bsg^fl^* allele could be specifically deleted in thymocytes and subsequent T lymphocytes in *Lck-Cre; Bsg^fl/fl^* mice. In addition, the *Bsg^fl/fl^* mice could be used for tissue-specific deletion of *basigin* using previously developed *Cre* transgenic mouse models.

Analysis of thymocytes from *Lck-Cre; Bsg^fl/fl^* mice
------------------------------------------------------

General observation and physical examination apparently showed that the *Lck-Cre; Bsg^fl/fl^* mice showed no obvious difference in development and growth compared to the control mice (*Bsg^fl/fl^*). No defects were found in the size and tissue structure of major organs in adult mice, including heart, lung, liver, kidney, and other organs. Previous reports have shown the involvement of basigin in thymus development *ex vivo*; thus, we examined whether the development of thymus was impaired in the absence of basigin in *Lck-Cre; Bsg^fl/fl^* mice. We isolated the thymus from 5-week-old mice and found a significant reduction in thymus weight in *Lck-Cre; Bsg^fl/fl^* mice compared to that in control mice (Fig. [3](#F3){ref-type="fig"}A left). The total number of thymocytes in *Lck-Cre; Bsg^fl/fl^* mice was approximately 29% lower compared to control mice (Fig. [3](#F3){ref-type="fig"}A right). Quantification of individual thymocyte subsets using flow cytometry with CD4 and CD8 mAbs showed that the number of DP and CD4SP thymocytes from *Lck-Cre; Bsg^fl/fl^* mice was reduced by 32% and 22%, respectively, compared to control mice (Fig. [3](#F3){ref-type="fig"}B and [3](#F3){ref-type="fig"}C). However, the absolute number of DN (double-negative, CD4^-^CD8^-^) and CD8SP (CD4^-^CD8^+^) thymocytes showed no significant difference between mice of the two different genotypes (Fig. [3](#F3){ref-type="fig"}C). Similar results were also found in the thymus from 2-week-old *Lck-Cre; Bsg^fl/fl^* mice and their control mice ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S1). The above results indicated that basigin expression in T lymphocytes is necessary for thymocyte development, particularly at the DP and CD4SP stage. Since the observed drop of cell number in thymus mainly came from DP subset, we assessed freshly isolated thymocytes by Annexin V versus PI staining to investigate whether increased apoptosis of DP thymocytes accounted for the reduced thymocyte numbers. However, there were no significant difference of apoptotic DP thymocytes between *Lck-Cre; Bsg^fl/fl^* mice and the control mice ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S2).

Analysis of peripheral T cells from *Lck-Cre; Bsg^fl/fl^* mice
--------------------------------------------------------------

We also analyzed the number of peripheral T cells isolated from the *Lck-Cre; Bsg^fl/fl^* mice. In contrast to the population variation found in thymocytes, the total number of splenocytes was slightly, but not significantly, reduced in *Lck-Cre; Bsg^fl/fl^* mice compared to control mice (Fig. [4](#F4){ref-type="fig"}A). An analysis of splenocytes using CD4 and CD8 mAbs also did not show significant changes in the percentage and total number of CD4^+^ T lymphocytes and CD8^+^ T lymphocytes (Fig. [4](#F4){ref-type="fig"}B and [4](#F4){ref-type="fig"}C). Because basigin has previously been reported to be highly expressed on activated T lymphocytes, we next analyzed whether T lymphocyte activation was affected in the absence of basigin expression. CD4^+^ T lymphocytes were isolated from the spleen, and stimulated with ConA, anti-CD3/CD28 antibodies, PMA/Ionomycin and control medium. In the control medium treatment group, no difference in the proliferative index was observed between the *Lck-Cre; Bsg^fl/fl^* mice and control mice. However, after stimulation with ConA and anti-CD3/CD28 antibodies, the proliferation index of the CD4^+^ T lymphocytes isolated from *Lck-Cre; Bsg^fl/fl^* mice was significantly increased compared to that of the CD4^+^ T lymphocytes from the control mice (Fig. [4](#F4){ref-type="fig"}D). In contrast, the proliferation index of CD4^+^ T lymphocytes from *Lck-Cre; Bsg^fl/fl^* mice stimulated with PMA/Ionomycin was the same as that of the control CD4^+^ T lymphocytes. To examine whether deletion of basigin enhanced T cell activation via T cell receptor (TCR), we measured the expression of CD69 on CD4^+^ T cells stimulated with anti-CD3/CD28 antibodies. As shown in Figure [4](#F4){ref-type="fig"}E, expression of CD69 was nearly undetectable in unstimulated CD4^+^ T cells from both *Lck-Cre; Bsg^fl/fl^* mice and control mice. However, expression level of CD69 on the CD4^+^ T cells from *Lck-Cre; Bsg^fl/fl^* mice was higher than that from control mice after stimulation. Consistent with the proliferation index result, the percentages of CD69^+^ cells were also significantly increased in stimulated CD4^+^ T cells from *Lck-Cre; Bsg^fl/fl^* mice compared to that from control mice (Figure [4](#F4){ref-type="fig"}F). Taken together, the above results indicated that basigin may regulate T cell activation via T cell receptor activation and may not directly regulate Ca^2+^ storage release and protein kinase C signaling pathway.

Discussion
==========

In this study, we generated a conditional null allele for *basigin* (*Bsg^fl^*) in mice using the *Cre-loxP* system. *Bsg^fl/fl^* mice were born at the expected Mendelian ratio and exhibited a growth rate similar to wildtype mice. Next, we generated *Lck-Cre; Bsg^fl/fl^*mice by intercrossing the *Bsg^fl/fl^* mice with *Lck-Cre* transgenic mice. In *Lck-Cre; Bsg^fl/fl^*mice, the floxed *basigin* gene was specifically inactivated in thymocytes and T lymphocytes but not in B lymphocytes or other somatic cells. A phenotypic analysis revealed that *Lck-Cre; Bsg^fl/fl^* mice showed no obvious difference in birth and growth rates compared to control mice, except for significant reduction in thymus weight and total number of thymocytes. Inactivation of basigin in T lymphocytes also significantly decreased the number of DP and CD4SP cells in the adult thymus, and enhanced the proliferation of CD4^+^ T cells upon ConA or anti-CD3/CD28 stimulation.

Basigin is a multifunctional protein that is thought to be involved in a variety of physiological and pathological activities, such as embryo development, reproduction, immune response and tumor metastasis [@B1], [@B3]-[@B5], [@B28]. However, the *in vivo* functions of basigin are still unclear, partly due to the shortage of appropriate experimental animal models. In addition, basigin knockout mice have been previously generated using a conventional gene targeting strategy [@B3]; however, only a very small number of *Bsg^-/-^* embryos survive to birth and develop into small, weak, and infertile adult mice. These developmental challenges prevented an elaborate phenotypic analysis and the establishment of some disease models. To overcome these disadvantages, Kadomatsu et al. generated a hybrid *Bsg^-/-^* mouse line known as "reverse F2," by intercrossing F2 animals from the F1 hybrid offspring of 129/SV chimera and C57BL/6J animals with a C57BL/6J congenic mouse line [@B35]. The "reverse F2" *Bsg^-/-^* mice were born at an expected frequency (\~20%), possibly because of the specific genetic background and the composition of the flanking region of the *Bsg* gene, but not the normal function of basigin. Moreover, because basigin is expressed in different cell types and may function via cell-cell interaction, knocking out basigin expression in all cells prevented the further study of its role in specific cell types and its corresponding cellular and molecular mechanisms. Here, we generated a conditional null allele for basigin using the *Cre-loxP* system. In contrast to the previously reported*Bsg^-/-^*mice, *Bsg^fl/fl^* mice showed no fertility and growth defects, indicating that the insertion of the *loxP* sites had no effect on *basigin* gene activity. Intercrossing *Bsg^fl/fl^* mice with *Lck-Cre* transgenic mice demonstrated an effective knockout of the *basigin* gene in cells with *lck* promoter activity (thymocytes and T lymphocytes), which demonstrated that *Bsg^fl/fl^* mice could be a very useful tool to study basigin\'s *in vivo* physiological and pathological functions in specific cell types and at different development stages.

*Lck-Cre; Bsg^fl/fl^* mice also showed no difference in birth and growth rate compared to control mice, which enabled further analysis of basigin\'s function in thymus development. First, we found that the thymuses of *Lck-Cre; Bsg^fl/fl^* mice were significantly smaller compared to control *Bsg^fl/fl^*mice, which was accompanied by a significant reduction in the number of thymocytes (Fig. [3](#F3){ref-type="fig"}A). Reno et al. previously reported that a basigin-specific mAb (RL73.2) could block the *ex vivo* development of fetal thymocytes into mature T cells by reducing the number of live cells in a fetal thymic organ culture, which predominantly occurred at the transition between the DN3 and DN4 stages; however, treatment with the mAb did not result in an increase in cell death in adult thymocytes [@B9]. Because the expression of the *Lck-Cre* transgene used in our study might be initiated after the DN2 stage [@B34], the inactivation of *basigin* was expected to begin as early as the DN3 stage. This may have contributed to the weak undeleted band observed in the PCR test using thymus genomic DNA obtained from the *Lck-Cre; Bsg^fl/fl^* mice (Fig. [2](#F2){ref-type="fig"}A). However, *Lck-Cre; Bsg^fl/fl^* mice did not show any significant change in the number of DN cells in the adult thymus, and exhibited a significantly decreased cell number of DP and CD4SP cells in the adult thymus compared to controls, which were inconsistent with Reno\'s findings. Our results showed an important *in-vivo*function of basigin in thymus development at the DP stage and CD4SP stage.

In contrast to the population variation found in the thymus, the relative proportions and absolute numbers of peripheral CD4 and CD8 T cell were similar between *Lck-Cre; Bsg^fl/fl^* mice and controls (Fig. [4](#F4){ref-type="fig"}B and [4](#F4){ref-type="fig"}C). The possible reason was that maintenance of the peripheral T cell population does not only depend on the influx of thymic emigrants cells, but also depend on the homeostatic mechanism [@B36]. When the number of peripheral T cells is severely depleted in some pathological case, the remaining T cells sense the increased availability of "space" and undergo spontaneous proliferation to re-establish homeostasis. Although the molecular basis remains unclear, interaction of TCR with self-peptide/MHC molecules seem to participate in the homeostatic proliferation of peripheral T cells [@B37]. We found that CD4^+^ T cells from *Lck-Cre; Bsg^fl/fl^* mice expressed higher level of CD69 (Fig [4](#F4){ref-type="fig"}E) and proliferated stronger after stimulation with anti-CD3/CD28 antibodies (Fig [4](#F4){ref-type="fig"}D and [4](#F4){ref-type="fig"}F), compared with the control cells. These results suggested that deletion of basigin may plays an important role in T cell activation and proliferation via elevating TCR signal strength. It is possible that deletion of basigin also augments the signals delivered by the complex of TCR and self-peptide/MHC molecules, and facilitates homeostatic proliferation of CD4^+^ T cells in *Lck-Cre; Bsg^fl/fl^* mice.

Igakura et al. previously found that the mitogenic response of lymphocytes upon a mixed lymphocyte reaction was greater in *Bsg^-/-^*mice [@B3], [@B29]. Our previous *in vitro*study showed that the engagement of basigin with a specific anti-basigin mAb in human T lymphocytes strongly inhibited T cell proliferation and disrupted the formation of the immunological synapse [@B12]. To the best of our knowledge, we are the first to show that the genetic ablation of basigin in T lymphocytes alone did not affect the proliferation or survival of CD4^+^ T cells isolated from the adult spleen but, rather, resulted in a significantly enhanced proliferation of CD4^+^ T cells upon ConA or anti-CD3/CD28 stimulation. This finding suggested that basigin may not to be a general regulator of T cell survival or proliferation but may suppress the activation or proliferation of T cells via TCR activation. Cytosolic Ca^2+^ dynamics is important for the precise control of T cell activation, and relies on the extracellular Ca^2+^ influx following TCR activation and intracellular storage release evoked by downstream signals of TCR stimulation. Our previous study showed that anti-basigin mAb could inhibit cytosolic Ca^2+^ concentrations when added together with anti-CD3/CD28 antibodies. However, in the present study, no difference in the T cell proliferation index was observed between the *Lck-Cre; Bsg^fl/fl^* mice and control mice upon PMA/Ionomycin stimulation, suggesting that the suppression of basigin on Ca^2+^ mobility may rely on TCR activation, or that basigin may only inhibit the TCR-mediated Ca^2+^ influx, but not the release of intracellular Ca^2+^. Further elucidation of the mechanistic functions of basigin in thymus development and T lymphocyte function are required and are currently ongoing in our lab. Moreover, *Lck-Cre; Bsg^fl/fl^* mice will be a useful tool for the exploration of basigin function in T lymphocytes.

To the best of our knowledge, this study presented the first *in vivo* evidence for the function of basigin in thymus development. In addition, the successful generation of the conditional null allele for basigin provides a useful tool for the tissue- and developmental stage-specific ablation of *basigin* using previously developed *Cre* transgenic mouse models.
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![Generation of the conditional null allele for *basigin*. **A.** Strategy for generating the conditional targeting vector, targeted *Bsg^fn^* allele, targeted*Bsg^fl^* allele and excised allele *Bsg^-^*. Flp-mediated excision of *Neo* cassette from the *Bsg^fn^*allele resulted in the *Bsg^fl^* allele, and Cre-mediated excision of the *loxP* sites resulted in the *Bsg^-^* allele. The 3\' external probe for the Southern blot is indicated by the thick lines. The predicted lengths of the Southern fragments are indicated by the double arrow lines. PCR primers used to identify the targeted and deleted alleles are indicated by the arrows. N, *Not I*. **B.** Correctly targeted ES cells were confirmed by Southern blot analysis. Genomic DNA was isolated from ES cells, digested with*Not I* and subjected to Southern blot analysis using a 3\' external probe as indicated in Fig. [1](#F1){ref-type="fig"}A. **C.** The 5\' arm homologous recombination events in targeted ES cells were confirmed by PCR using primers P1 and P2. **D.** Deletion of the *Neo*cassette was identified by PCR using primers P5 and P6.](ijbsv10p0043g001){#F1}

![Deletion of the *Bsg^fl^*allele in *Lck-Cre; Bsg^fl/fl^* mice. **A.** PCR analysis of the *basigin* deletion on genomic DNA obtained from the thymus, spleen and liver. Primers P3, P4 and P7 were added in a same tube for PCR reaction in this experiment.**B.** Real-time quantitative PCR. The relative mRNA level of basigin in CD4^+^ T cells isolated from *Bsg^fl/fl^*mice was presented as 1, and the mRNA levels of basigin in other cells were expressed as a relative ratio. *n* = 4. \*\*, *P*\< 0.01. **C.** Western blot analysis. Total protein from the CD4^+^ T cells and B cells were immunoblotted using an anti-basigin antibody. β-actin was used as the loading control.](ijbsv10p0043g002){#F2}

![Targeted disruption of the *basigin* resulted in a decrease in thymic cellularity. Thymocytes were obtained from 5-week-old mice.**A.** Thymus weight (left) and absolute cell number of total thymocytes (right) were assessed. n = 8 per group. **B.** Analysis of CD4^+^ and CD8^+^ thymocytes from *Lck-Cre; Bsg^fl/fl^* mice and their control littermates using flow cytometry. C. The absolute cell number of the DN, DP, CD4SP and CD8SP thymocytes. n = 8. *NS*, no significance. \*, *P*\< 0.05; \*\*, *P*\< 0.01.](ijbsv10p0043g003){#F3}

![Analysis of peripheral T cells from *Lck-Cre; Bsg^fl/fl^* mice and their control mice. T lymphocytes were freshly isolated from the spleens of 5-week-old*Lck-Cre; Bsg^fl/fl^* mice and their control mice. **A.** Analysis of the spleen weight and absolute cell number of total splenocytes. n = 8. **B.** Analysis of CD4^+^ and CD8^+^ T lymphocytes using flow cytometry. **C.** The absolute cell number of CD4^+^ and CD8^+^ T lymphocytes. n = 8. **D.** Proliferation analysis of CD4^+^ T lymphocytes stimulated with medium, ConA, anti-CD3/CD28 antibodies and PMA/Ionomycin. n = 4. **E.** CD69 expression in CD4^+^ T lymphocytes stimulated or unstimulated with anti-CD3/CD28 antibodies for 18 hours. **F.** Percentages of CD69 positive cell in CD4^+^ T lymphocytes. n = 3. \*, *P*\< 0.05.*NS*, no significance.](ijbsv10p0043g004){#F4}
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